Down-regulation of DAPK1 expression has been correlated with the severity of malignancy and lymph node metastasis in various cancers including lung cancer[37], urinary tract carcinoma[38], and esophageal squamous cell carcinoma[39]. This evidence concerns the gene DAPK1 and metastatic malignant neoplasm in the lymph nodes.